Destruction of Midbrain Dopaminergic Neurons by Using Immunotoxin to Dopamine Transporter |
| |
Authors: | R. G. Wiley M. B. Harrison A. I. Levey D. A. Lappi |
| |
Affiliation: | (1) Departments of Neurology and Pharmacology and Center for Molecular Neuroscience, Vanderbilt University and VA TVHS, Nashville, Tennessee, USA;(2) University of Virginia, Charlottesville, Virginia, USA;(3) Department of Neurology, Emory University, Atlanta, Georgia, USA;(4) Advanced Targeting Systems, San Diego, California, USA |
| |
Abstract: | 1. The ability to target specific neurons can be used to produce selective neural lesions and potentially to deliver therapeutically useful moieties for treatment of disease. In the present study, we sought to determine if a monoclonal antibody to the dopamine transporter (anti-DAT) could be used to target midbrain dopaminergic neurons.2. The monoclonal antibody recognizes the second, large extracellular loop of DAT. The antibody was conjugated to the ribosome-inactivating protein saporin, and stereotactically pressure microinjected into either the center of the striatum or the left lateral ventricle of adult, male Sprague-Dawley rats.3. Local intrastriatal injections produced destruction of dopaminergic neurons in the ipsilateral substantia nigra consistent with suicide transport of the immunotoxin. Intraventricular injections (i.c.v.) produced significant loss of dopaminergic neurons in the substantia nigra and ventral tegmental area bilaterally without evident damage to any other aminergic structures such as the locus coeruleus and raphé nuclei. To confirm the anatomic findings, binding of [3H]mazindol to DAT in the striatum and midbrain was assessed using densitometric analysis of autoradiograms. Anti-DAT-saporin injected i.c.v. at a dose of 21 g, but not 8 g, produced highly significant decreases in mazindol binding consistent with loss of the dopaminergic neurons.4. These results show that anti-DAT can be used to target midbrain dopaminergic neurons and that anti-DAT-saporin may be useful for producing a lesion very similar to the naturally occurring neural degeneration seen in Parkinson's disease. Anti-DAT-saporin joins the growing list of neural lesioning agents based on targeted cytotoxins. |
| |
Keywords: | molecular neurosurgery saporin immunolesioning substantia nigra striatum |
本文献已被 PubMed SpringerLink 等数据库收录! |
|